A new model of multi-visceral and bone metastatic prostate cancer with perivascular niche targeting by a novel endothelial specific adenoviral vector-Reference-Cited by-同舟云学术

A new model of multi-visceral and bone metastatic prostate cancer with perivascular niche targeting by a novel endothelial specific adenoviral vector

Published:2017-01-17 Issue:7 Volume:8 Page:12272-12289
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Lu Zhi Hong¹²,Kaliberov Sergey²³⁴,Sohn Rebecca E.¹²,Kaliberova Lyudmila²³⁴,Du Yingqiu¹²,Prior Julie L.⁵,Leib Daniel J.⁶,Chauchereau Anne⁷,Sehn Jennifer K.²⁸,Curiel David T.²³⁴,Arbeit Jeffrey M.¹²

Affiliation:

1. Urology Division and Department of Surgery, Washington University in St. Louis School of Medicine, St. Louis, MO 63110, USA

2. Siteman Cancer Center, Washington University in St. Louis School of Medicine, St. Louis, MO 63110, USA

3. Biologic Therapeutics Center, Washington University in St. Louis School of Medicine, St. Louis, MO 63110, USA

4. Department of Radiation Oncology, Washington University in St. Louis School of Medicine, St. Louis, MO 63110, USA

5. Radiology, Washington University in St. Louis School of Medicine, St. Louis, MO 63110, USA

6. Department of Orthopedic Surgery, Washington University in St. Louis School of Medicine, St. Louis, MO 63110, USA

7. Prostate Cancer Group, INSERM U981, Gustave Roussy, Villejuif, F-94805, France

8. Department of Anatomic and Molecular Pathology, Washington University in St. Louis School of Medicine, St. Louis, MO 63110, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a human glioblastoma model using humanized DRAG mice for immunotherapy;Antibody Therapeutics;2023-10-01

2. Development of a human glioblastoma model using humanized DRAG mice for immunotherapy;2023-02-16

3. Preclinical Efficacy of a PARP-1 Targeted Auger-Emitting Radionuclide in Prostate Cancer;International Journal of Molecular Sciences;2023-02-04

4. Current methods for studying metastatic potential of tumor cells;Cancer Cell International;2022-12-09

5. Impact of Novel Hormonal Agents (Abiraterone, Enzalutamide) on the Development of Visceral and/or Brain Metastases in Patients With Bone-metastatic Castration-resistant Prostate Cancer;Clinical Genitourinary Cancer;2022-10